Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
about
Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?Nonalcoholic Fatty liver disease and psoriasis: what a dermatologist needs to knowPsoriasis: classical and emerging comorbiditiesPsoriasis and comorbidities: links and risks.Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR)Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis.Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.Metabolic syndrome in patients with psoriatic disease.Extrahepatic Manifestations of Nonalcoholic Fatty Liver DiseaseNonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population?Psoriasis severity and the prevalence of major medical comorbidity: a population-based studyRelationship between psoriasis and non-alcoholic fatty liver disease.Comorbidities in Patients with Psoriatic Arthritis.The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.Psoriasis and non-alcoholic fatty liver disease.Hepatotoxicity related to antirheumatic drugs.Obesity and psoriasis: body weight and body mass index influence the response to biological treatment.Alcohol, psoriasis, liver disease, and anti-psoriasis drugs.The effects of alcohol on the metabolism and toxicology of anti-psoriasis drugs.Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis.Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies.Noninvasive Testing for Nonalcoholic Steatohepatitis and Hepatic Fibrosis in Patients With Psoriasis Receiving Long-term Methotrexate Sodium Therapy.Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register.Liver test abnormalities in patients admitted for severe psoriasis: prevalence and associated risk factors.Psoriasis and the liver: problems, causes and course.Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?Clinical symptoms and self-reported disease severity among patients with psoriasis - Implications for psoriasis management.Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis.The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic.Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease.A possible role of polycystic ovary syndrome for pregnancy complications in women with psoriasis.Digestive system in psoriasis: an update.End-stage methotrexate-related liver disease is rare and associated with features of the metabolic syndrome.Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study.Association of Psoriasis With Comorbidity Development in Children With Psoriasis.The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis.Psoriasis and inflammatory bowel disease: links and risks.Monitoring methotrexate-induced liver fibrosis in patients with psoriasis: utility of transient elastography.A Case-control Study to Evaluate the Prevalence of Nonalcoholic Fatty Liver Disease Among Patients with Moderate-to-severe Psoriasis.
P2860
Q26767276-5EBEBD01-D84B-443E-B7B0-556A6A11524AQ26998754-C1E666F5-F9F5-4793-BEDA-19C955D81D8AQ28088340-AABD8625-4D8D-44FA-A496-68133E6ABE66Q34418506-E3BB1307-25B0-4714-B96C-0E2AC9FB6164Q34516612-78C4E5CF-A6FE-49E4-8528-8CB1BE29EDFDQ35109287-63B6F63A-0406-4152-8207-2AA7A1B5AC6BQ35444953-399628BD-13EE-4858-BAAD-F5CB532426BEQ36252677-C227F375-06CA-489D-A8C2-79EDC98BF7E6Q36897095-87806E08-1815-4C92-A13C-07189EA21FFEQ36921610-3E46ABDB-D1F4-4E3F-B8FF-90D7D335BB04Q37077557-2C248370-776E-4243-95DD-FEFB2BF1C83FQ37239394-42A2F581-0061-43B2-A21D-78AF187B7DB3Q37553636-BDA2E7DB-DD30-4D28-B941-D738B7DF0082Q37632137-3F0BD6A8-BDD8-436C-AA37-2F483F12A07AQ37766229-20564A34-5067-4425-B8FD-5BAD5ED69544Q37788777-44E9CF36-7335-43BE-B299-E1DAE0C2FC7DQ37832129-96F6D5C7-364B-4F04-A24C-0DF92E8C25BAQ37865060-73179915-4CB2-4EB5-95B8-A03418F7D3C3Q37946497-E893FC0E-8A10-4E41-9B0D-4CAE93D38B4FQ38010769-C6490C58-0323-475A-B3EC-7904453949CEQ38058361-CD93A5D0-373B-48EA-B5B8-E13675BA2D14Q38194199-CD4928BE-454F-427C-AC17-DBBAEAB27D5BQ38612446-C4C2E2B5-EE4A-40B7-81D9-720B23D40751Q39004998-48006568-4963-4E73-B5AB-A8CA3DA26847Q39735574-EFD97C5B-5A81-4E29-8521-5894110AEB4AQ39967628-4641D1C7-B1A2-41CB-83C0-73BC16C994F5Q40837256-B051B437-D10C-41F3-B38F-53E9AB9E6FC8Q41053849-712BEBF9-9ECD-47BE-AFAD-7A6A3CDC5670Q41150051-501C3A56-C6B2-40B0-B116-66A186303DA4Q41673511-C7E8A9AF-8EBC-49C7-B3B7-FC8B41106BB8Q41749643-7DF479D9-B201-4F56-9170-B31FA32275D6Q45111540-9E0F84F0-556E-47E6-B464-CC085C2F2005Q46466020-C2C1ACA2-E570-4BA1-939C-AF28EFD65BECQ46699120-C94A5E00-DDC3-47FF-A10C-B405E6F2375EQ47690271-0D1C5E64-4A0F-4B6A-98B1-C53676301075Q50098636-4B4AA01F-65E5-4500-8275-640248A3C93EQ51350319-1F19136A-A762-45D0-89FB-63F5DB1300AFQ52859380-F9A12B83-00D9-4553-BF99-B90773866B1FQ55082101-35AD555B-720B-42F4-B614-E85BAF052085Q55255755-9979564A-66FF-41C4-92E8-78FF4AD33765
P2860
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Prevalence, characteristics an ...... with chronic plaque psoriasis.
@en
Prevalence, characteristics an ...... with chronic plaque psoriasis.
@nl
type
label
Prevalence, characteristics an ...... with chronic plaque psoriasis.
@en
Prevalence, characteristics an ...... with chronic plaque psoriasis.
@nl
prefLabel
Prevalence, characteristics an ...... with chronic plaque psoriasis.
@en
Prevalence, characteristics an ...... with chronic plaque psoriasis.
@nl
P2093
P50
P1476
Prevalence, characteristics an ...... with chronic plaque psoriasis.
@en
P2093
Antonio Grieco
Carmine Di Stasi
Clara De Simone
Consuelo Cefalo
Fabio M Vecchio
Gianludovico Rapaccini
Luca Miele
Magda D'Agostino
Marco Biolato
Maria L Gabrieli
P304
P356
10.1016/J.JHEP.2009.06.008
P577
2009-06-26T00:00:00Z